Approved and adopted the un-audited Financial Results of the Company for the Quarter and nine-months ended 31st December, 2020. Approved Limited Review Report for the Quarter ended 31st December, 2020.
This is to inform the exchange that the meeting of Board of Directors of the M/s. Bacil Pharma Limited has been duly convened on Saturday, 13th day of February, 2021 through Video Conferencing. The Board transacted following items: Approved and adopted the un-audited Financial Results of the Company for the Quarter and nine-months ended 31st December, 2020. Approved Limited Review Report for the Quarter ended 31st December, 2020. Other Items with the permission of Board. Please note that the Meeting of the Board of Directors commenced at 06.00 P.M. and concluded at 06.15 P.M Kindly take the note of the same and update on your records.
BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve the unaudited Financial Results for the Quarter and Nine months ended 31st December 2020.
This is to inform that the details of securities dematerialized/rematerialized during the quarter ended 31st December 2020 as required under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018 have been furnished by our Registrar and Share Transfer Agent to the Stock Exchanges where the shares of the Company are listed (copy enclosed). We hereby confirm and certify that: a. The securities comprised in the said certificate(s) have been listed on the stock exchange or exchanges where the earlier issued securities were listed; and b. The certificates have been mutilated and cancelled after due verification and name of the depositories has been substituted in our records as the registered owner within 30 days of its receipt.
BACIL PHARMA LTD. - 524516 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Prakash ShahDesignation :- Any Other